Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lamivudine and Adefovir Motif Variants Detected in chronic Hepatıtıs B patients.

La Clinica terapeutica - 1 Jan 2014

Ozekinci T, Mese S, Ozbek E, Atmaca S

Abstract excerpt

BACKGROUND AND AIMS: Chronic hepatitis B is an important health problem worldwide. Lamivudine, adefovir, entecavir and telbivudine are the oral drugs licensed for the treatment of patients with chronic hepatitis B. Implementation of antiviral therapy leads to the emergence of mutant strains during the treatment in chronic hepatitis B. Primary antiviral resistance may be rarely encountered. The aims of this study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Protein Domains
Share to Adenine
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Hepatitis B, Chronic

Share to Hepatitis B virus

Share to Lamivudine

Share to Organophosphonates

Source

Identifiers

PMID: 24589944
DOI: 10.7471/CT.2014.1654

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lamivudine and Adefovir Motif Variants Detected in chronic Hepatıtıs B patients.PMID 24589944Read ↗

Prevelance of common YMDD motif mutations in long term treated chronic HBV infections in a Turkish population.Semantic proximity Read ↗

Comparison of INNO-LIPA and TRUGENE assays for genotyping and drug-resistance mutations in chronic hepatitis B virus infection.Semantic proximity Read ↗

[YMDD motif variants detected by Inno-Lipa HBV DR assay in chronic hepatitis B patients during lamivudine therapy].Semantic proximity Read ↗

Lamivudine resistance in untreated chronic hepatitis B patients in Turkey.Semantic proximity Read ↗

[HBV gene variants and polymerse gene mutations in children with chronic hepatitis B in the course of the antiviral therapy].Semantic proximity Read ↗

[Detection of resistance mutations in chronic hepatitis B patients receiving antiviral therapy for over one year].Semantic proximity Read ↗

Drug Resistance Mutations in the Polymerase Gene of Hepatitis B Virus in Three Generations of Patients with Chronic Hepatitis BSemantic proximity Read ↗

[Genotype distribution of chronic hepatitis B and hepatitis C patients and investigation of the resistance patterns in hepatitis B cases].Semantic proximity Read ↗

[Natural YMDD motif mutations of HBV polymerase in the chronic hepatitis B virus infected patients].Semantic proximity Read ↗

YMDD motif mutations in chronic hepatitis B antiviral treatment naïve patients: a multi-center study.Semantic proximity Read ↗

Rate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection.Semantic proximity Read ↗

Drug Resistance Mutations in the Polymerase Gene of HBV in Three Generations of Patients with Chronic Hepatitis BSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.